CLYM
Climb Bio Inc
11.70$
-1.9%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -2.0% | -1.0% | +106.7% | -1.7% | -2.3% | -7.6% | -4.2% | -5.2% | -8.0% | -9.2% | +61.6% | |
| – | -1.9% | -0.9% | +106.9% | -12.6% | -21.6% | -35.2% | -12.9% | +4.1% | +16.4% | +7.1% | +64.6% | |
| – | +62.3% | +12.8% | +112.5% | -34.5% | -40.3% | -66.7% | -21.8% | +13.8% | +38.3% | -76.6% | +427.8% | |
| – | -0.6% | -1.7% | +112.5% | -13.3% | -21.9% | -35.0% | -13.6% | +2.6% | +16.3% | +8.4% | +67.1% | |
| – | +28.2% | -18.0% | – | – | +13.0% | +22.1% | – | – | – | – | – | |
| – | -4.1% | +2.8% | +26.8% | -8.5% | +55.0% | +38.6% | -10.0% | -19.9% | +37.1% | -41.0% | +57.4% | |
| – | -2.3% | +4.1% | +26.8% | -8.5% | +44.1% | +42.7% | -11.8% | -20.2% | +41.1% | -41.7% | +45.8% | |
| – | -16.7% | -32.6% | -55.6% | -42.0% | +170.7% | -1.3% | +43.2% | +2.7% | +12.3% | +2.7% | +90.5% | |
| – | -91.0% | +28.8% | +498.8% | -42.8% | +142.3% | +10.2% | +21.8% | -49.6% | +375.7% | -62.1% | +31.7% | |
| – | -2.0% | -1.1% | +108.9% | -1.6% | -3.2% | -8.7% | -3.9% | -4.7% | -9.3% | -7.7% | +61.8% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.9% | +1.2% | +9.8% | +120.8% | -3.4% | +4.2% | +0.2% | +0.6% | -0.9% | +1.2% | +11.7% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.